Clinical Trial Update: Role of Colchicine as Anti-Inflammatory Therapy in HFpEF [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial from Cairo University is evaluating whether colchicine can act as an anti-inflammatory therapy in heart failure with preserved ejection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Cairo University | Conditions: HFpEF - Heart Failure With Preserved Ejection Fraction | Phase 3 | Status: ACTIVE_NOT_RECRUITING